ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Epichemist
|
750 |
290K |
3 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
750
|
290K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Epichemist
|
750 |
290K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
750
|
290K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
10K |
4.6M |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
10K
|
4.6M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
Epichemist
|
92 |
41K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
92
|
41K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide accepted for Priority Review by Health Canada
|
|
Epichemist
|
8 |
4.6K |
11 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
8
|
4.6K
|
11
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
107 |
40K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
107
|
40K
|
1
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
107 |
40K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
40K
|
1
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
107 |
40K |
2 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
107
|
40K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Epichemist
|
2.9K |
710K |
8 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
2.9K
|
710K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Epichemist
|
236 |
85K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
236
|
85K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
10K |
4.6M |
26 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10K
|
4.6M
|
26
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
107 |
40K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
107
|
40K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Recent Departures
|
|
Epichemist
|
13 |
4.7K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
4.7K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Recent Departures
|
|
Epichemist
|
13 |
4.7K |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
4.7K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
10K |
4.6M |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
10K
|
4.6M
|
7
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change to executive management
|
|
Epichemist
|
7 |
3.0K |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
7
|
3.0K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
9 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
372
|
134K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
372
|
134K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
372
|
134K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
10K |
4.6M |
20 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
10K
|
4.6M
|
20
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
372
|
134K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
372
|
134K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
372
|
134K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
372
|
134K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Update - Notification of buy-back - CUV
|
|
Epichemist
|
8 |
2.1K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
8
|
2.1K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Epichemist
|
316 |
163K |
8 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
316
|
163K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
372
|
134K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Epichemist
|
579 |
260K |
20 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
579
|
260K
|
20
|
|
ASX - By Stock
|
BGL |
Re:
Latest BGL media coverage
|
|
Epichemist
|
58 |
27K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
58
|
27K
|
0
|
|
ASX - By Stock
|
BGL |
Re:
Latest BGL media coverage
|
|
Epichemist
|
58 |
27K |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
58
|
27K
|
5
|
|
ASX - By Stock
|
BGL |
Re:
Latest BGL media coverage
|
|
Epichemist
|
58 |
27K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
58
|
27K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
372 |
134K |
7 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
372
|
134K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
Epichemist
|
205 |
61K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
205
|
61K
|
1
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Becoming a substantial holder
|
|
Epichemist
|
20 |
8.2K |
7 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
20
|
8.2K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
ASCRS - The Beginning of Greatness!
|
|
Epichemist
|
32 |
10K |
10 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
32
|
10K
|
10
|
|
ASX - By Stock
|
BGL |
Re:
Charts!
|
|
Epichemist
|
657 |
307K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
657
|
307K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
Epichemist
|
103 |
40K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
103
|
40K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Epichemist
|
487 |
219K |
20 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
487
|
219K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
Epichemist
|
91 |
53K |
56 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
91
|
53K
|
56
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
10K |
4.6M |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
10K
|
4.6M
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Epichemist
|
2.9K |
710K |
9 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
2.9K
|
710K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
10K |
4.6M |
11 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
10K
|
4.6M
|
11
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Newsletter II - March 2024
|
|
Epichemist
|
20 |
7.1K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
20
|
7.1K
|
3
|
|
ASX - By Stock
|
BGL |
Re:
Ann: High-grade shoots identified at Deacon
|
|
Epichemist
|
39 |
17K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
39
|
17K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Epichemist
|
579 |
260K |
14 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
579
|
260K
|
14
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Epichemist
|
2.9K |
710K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
2.9K
|
710K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Upcoming Phase 2 Trial Announcement Dates
|
|
Epichemist
|
7 |
3.9K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
7
|
3.9K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Epichemist
|
579 |
260K |
12 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
579
|
260K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Epichemist
|
1.0K |
523K |
30 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
1.0K
|
523K
|
30
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Becoming a substantial holder
|
|
Epichemist
|
13 |
4.5K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
13
|
4.5K
|
1
|
|